Tsai's study aimed to observe the immunomodulatory function of SMYD3 by administering anti‐sense oligonucleotides treatment in mice, which impacted the expression of SMYD3 in both tumor and immune cells. This evidence concerns the gene SMYD3 and neoplasm.